22/06/2026
National Veterinary Institute and Tecon Pharmaceutical Inc. Strengthen Collaboration on Veterinary Diagnostic Technologies
The National Veterinary Institute (NVI) hosted a delegation from Tecon Pharmaceutical Inc., China, on June 12, 2026, as part of ongoing efforts to strengthen international collaboration in veterinary diagnostics.
The visit follows earlier engagements between the two institutions, including the recent visit of NVI's senior management and Board members to China, where both parties initiated discussions on strategic cooperation in veterinary diagnostic kit development and technology transfer.
A major outcome of the visit was the signing of a Non-Disclosure Agreement (NDA) between the two institutions, providing a framework for the secure exchange of scientific, technical, and commercial information necessary for collaborative research and product development.
Under the proposed partnership, Tecon Pharmaceutical Inc. will provide 24 different veterinary diagnostic kits covering molecular diagnostics, gold colloidal rapid tests, and serological (ELISA) diagnostic platforms.
The collaboration will include technical cooperation, capacity-building and training programs, field validation of diagnostic kits, performance evaluation studies, and reporting of validation results. Speaking during the signing ceremony, Dr. Takele Abayneh, Chief Executive Officer of the NVI, emphasized the importance of international partnerships in strengthening veterinary diagnostic.
Dr. Takele further noted that NVI is committed to fostering partnerships that facilitate technology transfer, knowledge exchange, and scientific advancement, in line with the institute's vision of becoming a regional center of excellence in veterinary vaccines, diagnostics, and biological products.
The Non-Disclosure Agreement was formally signed by Dr. Takele Abayneh, CEO of the National Veterinary Institute, and Mr. Zhou Yang , Manager of Africa and MENA Region at TECON pharmaceutical.